In HNSCC, APP has emerged as a prognostic biomarker, where its overexpression correlates with poor overall survival, increased proliferation, and invasion through the PI3K/AKT and Notch signaling pathways (Galvao, et al., 2023; Wang, et al., 2024). Here, APP is linked to head and neck squamous cell carcinoma.